First Trust Advisors LP Lannett CO Inc Transaction History

First Trust Advisors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 25, 2018	SELL	$4.75 - $14.5 $163,699 - $499,713	-34,463 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$13.3 - $17.45 $67,816 - $88,977	5,099 Added 17.36%	34,463 $469,000
Q1 2018 Apr 23, 2018	SELL	$14.7 - $24.95 $13,200 - $22,405	-898 Reduced 2.97%	29,364 $471,000
Q4 2017 Feb 08, 2018	BUY	$19.9 - $29.25 $88,674 - $130,338	4,456 Added 17.27%	30,262 $702,000
Q3 2017 Oct 24, 2017	BUY	$15.1 - $19.25 $389,670 - $496,765	25,806	25,806 $476,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.